Skip to main content
Premium Trial:

Request an Annual Quote

Turn 'Oops' into 'Oooh'

For several years, many researchers have begun to recognize the value of negative results in scientific publications. "For a variety of reasons, positive publication bias is a real phenomenon," says Retraction Watch's Ivan Oransky. "In clinical medicine, that can paint a more optimistic picture of a field than is actually the case. And in basic science, it can mean other scientists may repeat experiments that have already failed."

So BioFlukes, a publisher based in Bangalore, India, has decided to help remedy the situation. The company has announced that it will launch a new publication called the Journal of Errology — "a home for experiments that didn't work out," Oransky says. This way, researchers can publish negative results without any stigma attached. BioFlukes spokesman, Mahboob Imtiyaz, says the journal is meant to be a place where researchers can share their experiences with the community, and where scientists can learn from each other's mistakes.

BioFlukes still has a lot of work to do, Oransky says. They need to find an editor in chief, and don't yet have a solid date for launching the journal. But they've already begun to accept submissions, and Imtiyaz says researchers seem enthusiastic about the idea.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.